IP Library Granted Patent US 9,005,191
Granted Patent B2
US 9,005,191 · App. 14/076,011 · Granted Apr 14, 2015

Neuromodulation methods using balloon catheter

Inventors: Bobak Robert Azamian (Newport Coast, CA); Jonathan Allen Coe (Menlo Park, CA); Scott Bradley Vafai (Boston, MA)
Assignee: Metavention, Inc.
A61B18/1815A61B18/18A61B18/1492A61N7/022A61B18/24A61B2018/00023A61B2018/0022A61B2018/00404A61B2018/00434A61B2018/00529A61B2018/00577A61B2018/00791A61B2018/00839A61B2018/0212A61B2018/048A61B17/320068A61N5/00A61B17/00A61B17/32A61B18/02A61B18/04A61B18/06A61N7/00A61B17/00234A61B2017/00318A61B2018/1861
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,005,191
App. No.
14/076,011
Granted
Apr 14, 2015
Kind
B2
Abstract

According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.

Claims (44)

1. A method of facilitating modulation of nerves surrounding a hepatic artery of a subject, comprising:

inserting a balloon catheter into a vasculature of a subject,

wherein the balloon catheter comprises a balloon having at least one electrode positioned on an external surface of the balloon;

advancing a distal section of the balloon catheter to a location within a portion of a hepatic artery of the vasculature;

at least partially occluding the portion of the hepatic artery using the balloon catheter,

causing the at least one electrode to contact a wall of the portion of the hepatic artery at a target site;

denervating the portion of the hepatic artery at the target site using the balloon catheter sufficient to reduce a blood glucose level of the subject; and

removing the balloon catheter from the vasculature of the subject.

2. The method of claim 1 , wherein at least partially occluding the portion of the hepatic artery comprises fully occluding the portion of the hepatic artery.

3. The method of claim 1 , wherein the denervating is effective to reduce at least one of a hepatic norepinephrine or lipid level in the subject.

4. The method of claim 1 , wherein denervating the portion of the hepatic artery at the target site comprises denervating one or more sympathetic nerves of the hepatic plexus.

5. The method of claim 1 , wherein a contact pressure between 0.1 g/mm 2 and 100 g/mm 2 is exerted on the wall by the balloon catheter.

6. The method of claim 1 , wherein the location within the portion of the hepatic artery is within at least one of a common hepatic artery, a proper hepatic artery, a right hepatic artery or a left hepatic artery.

7. The method of claim 1 , further comprising positioning the balloon catheter within a gastroduodenal artery and denervating one or more nerves surrounding the gastroduodenal artery.

8. The method of claim 4 ,

wherein the balloon catheter is configured to deliver RF energy at a frequency in the range of 50 kHz to 5 MHz; and

wherein the RF energy delivered is sufficient to cause permanent ablation of the one or more sympathetic nerves.

9. The method of claim 1 , further comprising providing cooling to a portion of the wall adjacent to the target site.

10. A method of facilitating modulation of nerves surrounding a hepatic artery of a subject comprising:

inserting a balloon catheter into a vasculature of a subject,

wherein the balloon catheter comprises a catheter body and a distal balloon having at least one electrode positioned on an external surface of the balloon;

advancing a distal section of the balloon catheter to a location within a portion of a hepatic artery of the vasculature;

at least partially occluding the portion of the hepatic artery using the balloon catheter,

causing the at least one electrode to contact a wall of the portion of the hepatic artery at a target treatment site;

modulating one or more nerves that innervate at least one of a liver or a pancreas of the subject at the target treatment site using the balloon catheter sufficient to reduce a blood glucose level of the subject; and

removing the balloon catheter from the vasculature of the subject.

11. The method of claim 10 , wherein the balloon catheter comprises a plurality of electrodes configured to contact the wall at multiple locations.

12. The method of claim 10 , wherein the catheter body comprises a lumen configured to continuously infuse a fluid into the balloon.

13. The method of claim 10 , wherein the balloon comprises one or more hydrogel portions spaced around a circumference of the balloon.

14. The method of claim 10 , wherein the balloon catheter comprises two balloons, each balloon comprising at least one electrode, and wherein the method further comprises positioning a first balloon in a first branch of the hepatic artery and a second balloon in a second branch of the hepatic artery.

15. The method of claim 10 , wherein modulating one or more nerves that innervate at least one of the liver or the pancreas comprises denervating one or more sympathetic nerves of a hepatic plexus.

16. The method of claim 10 ,

wherein the balloon catheter is configured to deliver RF energy at a frequency in the range of 50 kHz to 5 MHz; and

wherein the RF energy is delivered to heat one or more sympathetic nerves adjacent to the wall of the hepatic artery to a temperature of up to 90 degrees Celsius and sufficient to cause ablation of the one or more sympathetic nerves.

17. A method of facilitating modulation of nerves surrounding a hepatic artery of a subject comprising:

providing an energy delivery device comprising an expandable balloon having at least one electrode, the energy delivery device configured for:

intravascularly accessing a portion of a hepatic artery;

causing the at least one electrode of the expandable balloon to contact a wall of the hepatic artery; and

delivering energy through the wall of the hepatic artery sufficient to denervate one or more sympathetic nerves associated with a liver.

18. The method of claim 17 ,

wherein the energy comprises radiofrequency (RF) energy at a frequency in the range of 50 kHz to 5 MHz, and

wherein the RF energy delivered is sufficient to cause ablation of the one or more sympathetic nerves.

19. The method of claim 17 , further comprising occluding the portion of the hepatic artery.

20. The method of claim 17 , wherein the denervation is effective to reduce at least one of a hepatic norepinephrine level, lipid level or blood glucose level in the subject.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2023
From: METAVENTION, INC.
To: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
Reel/Frame 064987/0161 →
RELEASE OF SECURITY INTEREST Recorded Aug 22, 2023
From: CUSTOMERS BANK (SUCCESSOR IN INTEREST TO SIGNATURE BANK)
To: METAVENTION, INC.
Reel/Frame 064670/0039 →
SECURITY INTEREST Recorded Jan 11, 2023
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 062349/0859 →
SECURITY INTEREST Recorded Oct 31, 2022
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 061602/0249 →
SECURITY INTEREST Recorded Jun 29, 2022
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 060358/0417 →
SECURITY INTEREST Recorded Dec 20, 2021
From: METAVENTION, INC.
To: SIGNATURE BANK
Reel/Frame 058433/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2013
From: AZAMIAN, BOBAK ROBERT; COE, JONATHAN ALLEN; VAFAI, SCOTT BRADLEY
To: METAVENTION, INC.
Reel/Frame 031578/0683 →
Continuity (4)
Continuation 13789509 · Mar 7, 2013
Continuation PCTUS2012068630 · Dec 7, 2012
Provisional Application 61568843 · Dec 9, 2011
Related Publication 20140066924A1 · Mar 6, 2014